Kenneth Bradley
Global Head, Infectious Diseases Discovery Immunology, Infectious Diseases and Ophthalmology, Roche Pharma Research & Early Development (pRED) Roche Innovation Center Basel
Ken Bradley serves as the Global Head of Discovery for Infectious Disease, where he oversees early research efforts to combat AMR and viral diseases such as hepatitis B and COVID19. He came to Roche in 2015 to lead Roche’s re-entry into antibiotics R&D aimed at tackling the growing threat of multidrug resistant bacteria. Prior to this, Ken was a Professor of Microbiology, Immunology and Molecular Genetics at the University of California, Los Angeles and served as the Director of the Molecular Screening Shared Resource, a high throughput screening center at the California NanoSystems Institute.